Welcome to the e-CCO Library!

P0337: Incidentally Diagnosed Inflammatory Bowel Disease: Prevalence and Long-Term Outcomes
Year: 2025
Source: ECCO'25
Authors: Tubal Bronzex7x7x7 S.M.(1)*;Shenoyx7x7x7 S.(2);Agrawalx7x7x7 M.(3);Colombelx7x7x7 J.F.(3);Rodríguez-Lagox7x7x7 I.(4);Ungarox7x7x7 R.C.(3);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0338: Early identification of pediatric inflammatory bowel disease based on machine learning with non-invasive data
Year: 2025
Source: ECCO'25
Authors: Wux7x7x7 H.(1)*;Sunx7x7x7 Y.H.(2);Tangx7x7x7 Z.F.(1);Qinx7x7x7 X.J.(2);Wangx7x7x7 Y.H.(1);Huangx7x7x7 Y.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P033: Anti-TNF-α therapy normalises aberrant cytokine production and homing profile of circulating dendritic cells in Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

P. Hendy*1, 2, D. Reddi2, D. Bernardo3, L. Durant2, A. Noble2, N. English2, S. Knight2, A. Hart1

Created: Friday, 22 February 2019, 9:49 AM
P033: Dendritic cells from patients with active IBD imprint pro-inflammatory α4β7+CLA+ T cells with potential for gut and skin homing
Year: 2021
Source: ECCO'21 Virtual
Authors: Gordon, H.(1);Rodger, B.(1);Hoti, I.(1);Lindsay, J.O.(2);Stagg, A.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P033: DSS-induced colitis is attenuated in sigma-1 receptor knockout mice
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Lόpez-Estévez S.*1, Aguilera M.1, Gris G.2, de la Puente B.2, Codony X.2, Zamanillo D.2, Martínez V.1

Created: Wednesday, 20 February 2019, 10:36 AM
P033: Periostin regulates ER-stress mediated intestinal subepithelial myofibroblasts function to promote fibrosis in Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

C. Li*1, J. Kuemmerle1

Created: Friday, 22 February 2019, 9:41 AM
P033: Single-cell analysis of gut mucosal- and peripheral blood cells in ulcerative colitis patients undergoing vedolizumab treatment
Year: 2022
Source: ECCO'22
Authors: Karmi, N.(1);Sun, S.(1);de Jong, S.(1);Bangma, A.(1);Teunis, J.(2);Paraskevopoulou, M.(3);Juarez, J.(3);Bleck, B.(3);Farahmand, S.(3);Weersma, R.(1);Bigaeva, E.(1);Festen, E.(1);
Created: Friday, 11 February 2022, 3:52 PM
P033: The assessment of serum cytokines at baseline could predict mucosal healing in patients with Crohn's disease treated with ustekinumab. A prospective study.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: BertaniMD, L.(1)*;Antonioli, L.(2);Fornili, M.(2);D'Antongiovanni, V.(2);Coppini, F.(1);Ceccarelli, L.(3);Carmisciano, L.(2);Benvenuti, L.(2);Mumolo, M.G.(3);Bottari, A.(1);Baglietto, L.(2);Bellini, M.(1);Fornai, M.(2);De Bortoli, N.(1);Costa, F.(3);
Created: Friday, 14 July 2023, 10:48 AM
P033: The efficacy of tonsil-derived mesenchymal stem cells conditioned medium in chronic colitis model
Year: 2018
Source: ECCO '18 Vienna
Authors:

A.R. Choe*, S.-A. Jung, Y.-H. Joo, C.H. Tae, S.Y. Han, H.K. Jeon, J.W. Kim, S.H. Park, C.M. Moon, S.-E. Kim, K.-N. Shim, H.-K. Jung

Created: Thursday, 21 February 2019, 9:14 AM
P034 GB004, a novel gut-targeted prolyl hydroxylase inhibitor, induces HIF-1α target genes and is efficacious in mouse colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

K. Taylor Meadows1, M. Kennedy2, Z. Naiman1, M. Sergeeva2, B. Paulson2, G. Opiteck3, D. Slee4, L. Carter1, L. Salter-Cid4

Created: Thursday, 30 January 2020, 10:12 AM
P0340: Endo-Histo Foundational Fusion Model: A Novel Artificial Intelligence Approach for Predicting Histologic Remission and Early Response to Therapy in a Phase 2 Ulcerative Colitis Clinical Trial
Year: 2025
Source: ECCO'25
Authors: Iacuccix7x7x7 M.(1)*;Santacrocex7x7x7 G.(1);Meseguerx7x7x7 P.(2x7x7x73);Del Amorx7x7x7 R.(2);Diéguezx7x7x7 A.(2);Kolawolex7x7x7 B.B.(4);Chaudhurix7x7x7 U.(4);Zammarchix7x7x7 I.(1);Hayesx7x7x7 B.(5);Crottyx7x7x7 R.(5);Zardox7x7x7 D.(6);Maedax7x7x7 Y.(1);Puga-Tejadax7x7x7 M.(1);Ditonnox7x7x7 I.(1);Vadorix7x7x7 V.(4);Burkex7x7x7 L.(5);Gottliebx7x7x7 K.T.(7);Owenx7x7x7 C.(7);Eastmanx7x7x7 W.J.(7);Ghoshx7x7x7 S.(1);Grisanx7x7x7 E.(4);Naranjox7x7x7 V.(2);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0341: Variation in healthcare utilisation amongst IBD care centres in Australia and New Zealandx7x7x7 Crohn’s Colitis Care Data Insight’s Program.
Year: 2025
Source: ECCO'25
Authors: Sux7x7x7 W.K.(1x7x7x72x7x7x73);Wilsonx7x7x7 W.(4);Warkx7x7x7 G.(1);Walkerx7x7x7 G.(5x7x7x76x7x7x77);Sux7x7x7 H.(8);Forbesx7x7x7 A.(9);Kimx7x7x7 A.(10x7x7x711);Gilesx7x7x7 E.(12x7x7x713x7x7x714);Lawrancex7x7x7 I.(15x7x7x716);Duttx7x7x7 S.(17);Brettx7x7x7 L.(18);Begunx7x7x7 J.(19x7x7x720);Lynchx7x7x7 K.(21x7x7x722);Andrewsx7x7x7 J.M.(3x7x7x721x7x7x722);Connorx7x7x7 S.J.(1x7x7x73x7x7x723)*;
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0342: Quantitative faecal immunochemical test (qFIT) is comparable to calprotectin as a biomarker of IBD: Prospective longitudinal analysis of disease activity and endoscopic mucosal healing
Year: 2025
Source: ECCO'25
Authors: Cartlidgex7x7x7 P.(1)*;Le-Saint Grant x7x7x7 A.(1);Siu-Ying Laux7x7x7 P.(1);Hodgex7x7x7 M.(1);Hallx7x7x7 R.(2);Strachanx7x7x7 J.(3);Chuahx7x7x7 S.(4);Whelanx7x7x7 R.(1);Ongx7x7x7 S.(1);Brownsonx7x7x7 E.(5);Campbellx7x7x7 I.(5);Poulose x7x7x7 B.(6);Oddyx7x7x7 A.(6);MacDonaldx7x7x7 J.(7);Seenanx7x7x7 J.P.(5);Gayax7x7x7 D.(7);Mowatx7x7x7 C.(2);Hox7x7x7 G.T.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0343: Gender Identity and Inflammatory Bowel Disease: The Patient Perspective
Year: 2025
Source: ECCO'25
Authors: Colwillx7x7x7 M.(1x7x7x72)*;Jacobx7x7x7 K.(1);Pollokx7x7x7 R.(2);Poullisx7x7x7 A.(2);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0344: Comparative analysis of a simple POPSIL score with Lémann Index to define the burden of organ damage in Crohn’s disease.
Year: 2025
Source: ECCO'25
Authors: Ongx7x7x7 S.(1)*;Grant x7x7x7 R.(2);Cartlidgex7x7x7 P.(1);Campbellx7x7x7 I.(3);Hallx7x7x7 R.(4);MacDonaldx7x7x7 J.(5);Seenanx7x7x7 J.P.(3);Mowatx7x7x7 C.(4);Chuahx7x7x7 C.S.(6);Kallax7x7x7 R.(1);Hox7x7x7 G.T.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0345: Tailoring Crohn’s disease surveillance in clinical remission: new insights from the Lewis score
Year: 2025
Source: ECCO'25
Authors: Ferreirax7x7x7 A.I.(1x7x7x72x7x7x73)*;Lima Capelax7x7x7 T.(1x7x7x72x7x7x73);Xavierx7x7x7 S.(1x7x7x72x7x7x73);Arieirax7x7x7 C.(1x7x7x72x7x7x73);Rosax7x7x7 B.(1x7x7x72x7x7x73);Cotterx7x7x7 J.(1x7x7x72x7x7x73);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0346: Pouch Fistulas: Experience From a Tertiary Center
Year: 2025
Source: ECCO'25
Authors: Tubal Bronzex7x7x7 S.M.(1)*;Wongx7x7x7 S.Y.(2);Waitex7x7x7 H.(3);Plietzx7x7x7 M.(3);Hahnx7x7x7 S.(4);Greensteinx7x7x7 A.(4);Syllax7x7x7 P.(4);Khaitovx7x7x7 S.(4);Colombelx7x7x7 J.F.(3);Kayalx7x7x7 M.(3);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0347: Correlation between histologic disease activity in the distal and proximal colon in Ulcerative Colitis: A flexible sigmoidoscopy is insufficient to assess histology
Year: 2025
Source: ECCO'25
Authors: De Marcox7x7x7 D.(1)*;Meadler Kronx7x7x7 C.(2);Marcusx7x7x7 V.(2);Bittonx7x7x7 A.(1);Lakatosx7x7x7 P.(1);Wildx7x7x7 G.(1);Afifx7x7x7 W.(1);Bessissowx7x7x7 T.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0348: Ultrasound enterography with a novel ultrasound contrast agent for Crohn's Disease
Year: 2025
Source: ECCO'25
Authors: Gjengstoex7x7x7 A.J.(1)*;Volkmannx7x7x7 H.L.V.(1);Azizx7x7x7 A.(2);Dimcevskix7x7x7 G.(3);Giljax7x7x7 O.H.(1);Nylundx7x7x7 K.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0349: Gasdermin D: A New Inflammatory Biomarker in Assessing Clinical Disease Activity in Crohn’s Disease
Year: 2025
Source: ECCO'25
Authors: Buldukoglu x7x7x7 O.C.(1);Ocal x7x7x7 S.(1);Atar x7x7x7 G.E.(1);Kaya x7x7x7 B.(1);Isik x7x7x7 M.D.(1);Aydin Tigli x7x7x7 G.(2);Akca x7x7x7 S.(1);Akbay Harmandar x7x7x7 F.(1);Cekin x7x7x7 Y.(2);Cekin x7x7x7 A.H.(1)*;
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session